All News

Soon it won’t be possible to fund the huge enterprises of the leading pharma companies with a handful of blockbuster drugs. The only question is whether they can change and innovate in time.

Pollsters find most academics now back reforms to collaborate with business, increase private funding and streamline curricula.

The days of medical charities passively handing out grants and waiting to hear of any results are over. Now the money comes attached to sophisticated, target-driven deals.

Don't fall in love with your technology, advises Dinko Valerio, a leading Dutch bio entrepreneur and VC.

A Europe-wide survey carried out by ProTon Europe has found that European collaboration between industry and universities outstrips that of the US.

French biotech consultants Bionest Partners has a system for valuing loss-making biotech companies using information available on a company website.

The German state of Rheinland-Pfalz has supported the opening of a new innovation cluster to carry out research and development in the commercial vehicle sector.